End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.22 CNY | +2.51% | +3.55% | -.--% |
Business Summary
Number of employees: 2,986
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biological Product
73.3
%
| 1,556 | 66.8 % | 2,100 | 73.3 % | +34.93% |
Chinese Patent Medicine
12.5
%
| 404 | 17.4 % | 358 | 12.5 % | -11.42% |
Chemical Synthetic Medicine
6.2
%
| 147 | 6.3 % | 179 | 6.2 % | +21.09% |
Raw Material
3.2
%
| 72 | 3.1 % | 92 | 3.2 % | +26.86% |
Others
2.8
%
| 74 | 3.2 % | 79 | 2.8 % | +6.49% |
Technical Services
2.0
%
| 76 | 3.3 % | 58 | 2.0 % | -23.63% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.7
%
| 2,323 | 99.6 % | 2,858 | 99.7 % | +23.05% |
Global
0.2
%
| 4 | 0.2 % | 5 | 0.2 % | +9.36% |
Foreign
0.1
%
| 4 | 0.2 % | 3 | 0.1 % | -27.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Li Hua Song
CEO | Chief Executive Officer | 67 | 01/93/01 |
Xian Yu Du
CHM | Chairman | 54 | - |
Jian Ping Yao
PSD | President | 52 | - |
Yuan Yuan Zhou
BRD | Director/Board Member | 52 | 16/22/16 |
Zeng Li Li
BRD | Director/Board Member | 43 | - |
Jun Pei Jiang
BRD | Director/Board Member | 47 | - |
Yong Bin Wang
BRD | Director/Board Member | 56 | 05/13/05 |
Kun Li
BRD | Director/Board Member | 42 | - |
62 | - | ||
Hui Zhao
BRD | Director/Board Member | 50 | 09/07/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Zhao
BRD | Director/Board Member | 50 | 09/07/09 |
Li Hua Song
CEO | Chief Executive Officer | 67 | 01/93/01 |
Li Ming Song
BRD | Director/Board Member | 62 | 01/03/01 |
Xian Yu Du
CHM | Chairman | 54 | - |
Guang Fu Liu
BRD | Director/Board Member | 68 | 27/10/27 |
Kun Li
BRD | Director/Board Member | 42 | - |
Yong Bin Wang
BRD | Director/Board Member | 56 | 05/13/05 |
Jun Pei Jiang
BRD | Director/Board Member | 47 | - |
Zeng Li Li
BRD | Director/Board Member | 43 | - |
Yuan Yuan Zhou
BRD | Director/Board Member | 52 | 16/22/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,676,826,758 | 1,540,332,671 ( 91.86 %) | 42,548,606 ( 2.537 %) | 91.86 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,187,406 | 0.36% | 5,631,517 $ |
Company contact information
Anhui Anke Biotechnology (Group) Co., Ltd.
K-1, Guanhai Road 669 Changjiang West Road
230088, Hefei
+
http://www.ankebio.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.36B | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.39% | 31.28B | |
+57.86% | 25.27B | |
-15.91% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-10.53% | 7.94B |
- Stock Market
- Equities
- 300009 Stock
- Company Anhui Anke Biotechnology (Group) Co., Ltd.